Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Current Assets of $251.7 million for Q1 2026, down 33.1% year-over-year from $376.3 million in Q1 2025, and down 15.03% quarter-over-quarter from $296.3 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Current Assets (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $251.7 million for Q1 2026.
- In Q1 2026, Current Assets fell 33.1% year-over-year to $251.7 million; the TTM figure through Mar 2026 stood at $251.7 million (down 33.1% YoY), while the FY2025 annual figure was $296.3 million, down 30.97% from the prior year.
- Current Assets for Q1 2026 stood at $251.7 million, down from $296.3 million in the prior quarter.
- The five-year high for Current Assets was $847.9 million in Q4 2022, with the low at $251.7 million in Q1 2026.
- The 5-year median for Current Assets is $679.1 million (2024), against an average of $587.9 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 45.49% in 2022, then slumped 52.02% in 2025.
- Maravai Lifesciences Holdings' Current Assets stood at $847.9 million in 2022, then decreased by 17.45% to $699.9 million in 2023, then slumped by 38.69% to $429.1 million in 2024, then plunged by 30.97% to $296.3 million in 2025, then fell by 15.03% to $251.7 million in 2026.
- Business Quant data shows MRVI's Current Assets at $251.7 million in Q1 2026, $296.3 million in Q4 2025, and $325.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 155.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 155.66 Mn |
| Mar 31, 2026 | 251.74 Mn |
| Dec 31, 2025 | 296.25 Mn |
| Sep 30, 2025 | 325.87 Mn |
| Jun 30, 2025 | 359.76 Mn |
| Mar 31, 2025 | 376.28 Mn |
| Dec 31, 2024 | 429.15 Mn |
| Sep 30, 2024 | 679.14 Mn |
| Jun 30, 2024 | 681.50 Mn |
| Mar 31, 2024 | 667.88 Mn |
| Dec 31, 2023 | 699.91 Mn |
| Sep 30, 2023 | 700.87 Mn |
| Jun 30, 2023 | 699.31 Mn |
| Mar 31, 2023 | 765.51 Mn |
| Dec 31, 2022 | 847.90 Mn |
| Sep 30, 2022 | 835.53 Mn |
| Jun 30, 2022 | 759.38 Mn |
| Mar 31, 2022 | 619.14 Mn |
| Dec 31, 2021 | 740.04 Mn |
| Sep 30, 2021 | 687.48 Mn |